All relevant data have been included in the paper. Due to ethical restrictions, individual data from the current study are available upon request from the corresponding author. The corresponding author Dr Anil Nigam may be contacted at: <anil.nigam@icm-mhi.org>.

Introduction {#sec001}
============

Cognitive impairment in patients with cardiovascular disease (CVD) includes deficits in memory, attention, executive function and psychomotor speed \[[@pone.0183791.ref001]--[@pone.0183791.ref004]\], and has been related to loss of gray matter in various brain regions \[[@pone.0183791.ref005]\], cerebral atrophy \[[@pone.0183791.ref006]\] and low resting cardiac output \[[@pone.0183791.ref007]\]. Whether vascular or blood flow abnormalities mediate some or all of these potential mechanisms remains a question of debate. Patients with CVD often exhibit lower cerebral oxygenation during maximal incremental exercise compared to healthy controls, cerebral oxygenation being related to $\overset{˙}{V}\text{O}_{2}$ peak, ventilatory threshold and resting cardiac function \[[@pone.0183791.ref008]--[@pone.0183791.ref010]\]. At the same time, chronic exercise has been shown to slow or prevent age-related decline in cognitive function among otherwise healthy individuals and has been related to improved cerebral blood flow \[[@pone.0183791.ref011]\]. In a recent study in both young and older healthy individuals, even acute exercise was associated with an improvement in cognitive function during exercise, indicating dynamic factors influence cognitive function \[[@pone.0183791.ref012]\]. Furthermore, at rest, higher cerebral blood flow (measured by transcranial Doppler) was associated with faster response times to cognitive test (Stroop) in both young and old and to a similar degree \[[@pone.0183791.ref012]\]. However, during exercise, cerebral blood flow (measured by transcranial Doppler) increased similarly in both groups and was unaltered by cognitive stroop tasks. In contrast, prefrontal cortical hemodynamic near-infra red spectroscopy (NIRS) measures \[oxyhemoglobin (O~2~Hb) and total hemoglobin (tHb)\] were differentially affected by exercise intensity, age and cognitive task; e.g., there were smaller increases in O~2~Hb and tHb in the older group between exercise intensities (P\<0.05) \[[@pone.0183791.ref012]\]. These data indicate that: 1) Regardless of age, cognitive (executive) function is improved while exercising; 2) while cerebral blood flow (measured by transcranial Doppler) is strongly related to cognition at rest, this relation becomes uncoupled during exercise, and 3) there is dissociation between global CBF and NIRS regional cortical oxygenation and blood volume markers during exercise and engagement of prefrontal cognition.

Taken together, these previous studies suggest that several factors modulate cognitive function such as age, aerobic fitness and cardiovascular disease (such as coronary heart disease (CHD)) \[[@pone.0183791.ref011], [@pone.0183791.ref013], [@pone.0183791.ref014]\]. As well, based on the "vascular hypothesis" it has been suggested, particularly in patients with CHD, that a lower $\overset{˙}{V}\text{O}_{2}$ peak, cardiac function and cerebrovascular reserve (measured by NIRS) during exercise may be related to cognitive function \[[@pone.0183791.ref008]--[@pone.0183791.ref011], [@pone.0183791.ref013], [@pone.0183791.ref014]\], but this has not been explored yet. To our knowledge, no study has evaluated whether stable "fit" patients with CHD that regularly exercise (involved in long-term phase III cardiac rehabilitation) exhibit a similar degree of resting cognitive function compared to fit age-matched healthy controls, and whether cardiac and cerebral hemodynamic responses during maximal exercise may contribute to potential differences in cognitive function between groups. The objectives of this study were therefore 1) to evaluate cognitive function in a sample of fit CHD patients in comparison to a group of fit, age-matched healthy and younger controls, and 2) evaluate potential relationships between cognitive function, functional capacity and hemodynamic responses among groups. We hypothesized that cerebral oxygenation, cardiac hemodynamic responses, $\overset{˙}{V}\text{O}_{2}$ peak as well as cognitive function would be lower in patients with CHD compared to healthy controls, and that cognitive function would be related to cerebral oxygenation, cardiac hemodynamic responses and $\overset{˙}{V}\text{O}_{2}$ peakbased on the cerebrovascular reserve hypothesis \[[@pone.0183791.ref013]\].

Material and methods {#sec002}
====================

Subjects {#sec003}
--------

A total of 67 adults were prospectively enrolled from 2010 to 2014 in consecutive fashion, from the Cardiovascular Prevention and Rehabilitation Centre of the Montreal Heart Institute, including 25 fit patients with stable CHD, 20 age-matched healthy controls and 22 young healthy controls ([Fig 1](#pone.0183791.g001){ref-type="fig"} Flow chart and the Inclusion/Exclusion Criteria section of the [S1 File](#pone.0183791.s001){ref-type="supplementary-material"}). Patients with CHD were defined as "stable" for their disease because of the following exclusion criteria used: recent acute coronary syndrome (\<3 months), uncontrolled hypertension, recent bypass surgery intervention \<3 months, recent percutaneous transluminal coronary angioplasty \<6 months, left ventricular ejection fraction \<45%, pacemaker or implantable cardioverter defibrillator, recent modification of medication \<2 weeks. All subjects provided written informed consent and the protocol was approved by the Ethics Committee of the Montreal Heart Institute. The study was registered on ClinicalTrials.gov under identifier number: NCT03018561. All subjects underwent a baseline evaluation including a medical history, physical examination with measurement of height and weight, body composition (bioimpedance, Tanita, model BC418, Japan) and fasting blood sample (glucose and lipid profile) \[[@pone.0183791.ref015]\]. All subjects performed cognitive testing at rest and a maximal cardiopulmonary exercise test (CEPT) with gas exchange analysis. During CEPT, cerebral oxygenation and cardiac hemodynamic responses were measured continuously (see measurements section for details).

![Flowchart of the inclusion of the subjects.](pone.0183791.g001){#pone.0183791.g001}

Measurements {#sec004}
------------

### Cognitive function evaluation {#sec005}

Resting cognitive function was performed by a clinical neuropsychologist with training in cognitive test administration and evaluated using a validated paper-and-pencil neuropsychological battery test \[[@pone.0183791.ref016], [@pone.0183791.ref017]\]. Mini-Mental State examination (MMSE) and Geriatric Depression Scale (GDS) and were used to exclude patients suffering from depression and mental disease. A score \< 26/30 on the MMSE and \> than 10 on the GDS resulted in exclusion. This battery included the following tests: *a* Digit Span (Forward and Backward) (short-term and working memory). In this test, the neuropsychologist gave a series of numbers at the rate of about one per second. Following presentation, the subjects repeats the numbers in the order they were presented (Digits Forward) or in reverse order (Digits Backward). *b*. Digit Symbol Substitution Test (attention & processing speed), In this test, the participant had to associate symbols to numbers (1 to 9), in a table of numbers, by referring to a response key. The participant had 120 seconds to draw as many symbols as possible. *c*. Trail making test, part A and B. In the Trail Making Test part A, the participant had to connect numbers (from 1 to 25) with straight lines as fast as possible. In Part B, which measures flexibility, the participant had to alternate between letters in alphabetical order and numbers in ascending order (1-A-2-B-3-C, etc.) as fast as possible. *d*. D-KEFS Color-Word Interference Stroop Test: The Modified Stroop color test includes four conditions and provides a measure of inhibition and mental flexibility. In the reading condition (1), the participant had to read aloud color words as fast as possible. In the naming condition (2) they had to name the color of rectangles. In the inhibition condition (3), color-words were printed in a color that differed from their meaning (e.g., red printed in green) and the task was to name the ink color (green) and avoid reading the word. In the flexibility condition (4), the participant had to alternate between naming the color of the color-words, and reading the words (when the color-words appear in a square). Typically, scores in the more difficult conditions (3 & 4) are considered representative of executive control. In all conditions, word lists were printed on a sheet of paper and participants had to provide their answer verbally as fast as possible. e. Rey Auditory Verbal Learning Test (RAVLT, long-term verbal memory). In the RAVLT, participant must learn and remember a list of 15 words immediately after learning them and after a delay.

### Maximal cardiopulmonary exercise testing {#sec006}

Exercise testing was performed on an ergocycle (Ergoline 800S, Bitz, Germany) with an individualized protocol that included a 3-min warm up at 20 Watts, followed by a power increase of 10 to 20 Watts/min until exhaustion at a free pedaling speed \> 60 rpm \[[@pone.0183791.ref018]--[@pone.0183791.ref020]\]. Gas exchange was measured continuously at rest, during exercise, and after exercise cessation using a metabolic system (Oxycon Pro, Jaegger, Germany). The calibration of the flow module was accomplished by introducing a calibrated volume of air at several flow rates with a 3-liter pump. Gas analyzers were calibrated before each test using a standard certified commercial gas preparation (O~2~: 16%; CO~2~: 5%). Data were measured every four respiratory cycles during testing and then were averaged every 15 sec for minute ventilation ($\overset{˙}{V}\text{E}$, in l/min, BTPS), oxygen uptake ($\overset{˙}{V}\text{O}_{2}$, in l/min, STPD), carbon dioxide production ($\overset{˙}{V}\text{CO}_{2}$, in l/min, STPD) \[[@pone.0183791.ref018], [@pone.0183791.ref021]\]. Maximal exercise test lasted until the attainment of one of the two primary maximal criteria: (A) a plateau of $\overset{˙}{V}\text{O}_{2}$ despite an increase in cadence, (B) R.E.R \> 1.1, or one of the two secondary maximal criteria: (C) measured maximal heart rate attaining 95% of age-predicted maximal heart rate, (D) inability to maintain the cycling cadence, (E) subject exhaustion with cessation caused by fatigue and/or other clinical symptoms (dyspnea, abnormal BP responses) or ECG abnormalities that required exercise cessation. The ventilatory threshold was determined using a combination of the V-slope, ventilatory equivalents, and end-tidal oxygen pressure methods. The highest $\overset{˙}{V}\text{O}_{2}$ value reached during the exercise phase of each test was considered as the $\overset{˙}{V}\text{O}_{2}$ peak and peak power output (PPO) was defined as the power output reached at the last fully completed stage \[[@pone.0183791.ref018]--[@pone.0183791.ref020]\].

### Cerebral oxygenation/perfusion {#sec007}

Cerebral oxygenation/perfusion was measured using a near-infrared spectroscopy (NIRS) system (Oxymon Mk III, Artinis Medical, Netherlands) during maximal exercise and recovery \[[@pone.0183791.ref019], [@pone.0183791.ref022], [@pone.0183791.ref023]\]. Optodes were placed on the left prefrontal cortical area between Fp1 and Fp3, according the modified international EEG 10--20 system \[[@pone.0183791.ref019], [@pone.0183791.ref022], [@pone.0183791.ref023]\]. During exercise test, optodes were secured with a tensor bandage wrapped around the forehead, a neoprene pad was place between the skin and the optodes plastic holder and ambient room light (dimmer) was reduced. To correct for scattering of photons in the tissue, a differential path-length factor of 5.93 was used for the calculation of absolute concentration changes with an interoptode distance of 45 mm. Data were sampled at 10 Hz during the rest period (3 min), the exercise phase and the 5-min recovery period. Data were displayed in real time and stored on disk for off-line analysis. Raw NIRS signals were filtered via the oxysoft/DAQ software (Artinis Medical, Netherlands) using a running average function with a filter width of 1. Thereafter, NIRS signals were exported into excel files with the oxysoft/DAQ software at 0.2 Hz for statistical treatment. Relative concentration changes (ΔμM) were measured from resting baseline of oxyhaemoglobin (ΔO~2~Hb), deoxyhaemoglobin (ΔHHb), total haemoglobin (ΔtHb) = (ΔO~2~Hb)+ (HHb) and differential haemoglobin (ΔHb diff.) = (ΔO~2~Hb)-(HHb). The baseline period was set at the end of the 3-min resting period, defined as 0 μM \[[@pone.0183791.ref019], [@pone.0183791.ref022], [@pone.0183791.ref023]\].

### Cardiac hemodynamics {#sec008}

Cardiac hemodynamics were measured continuously at rest, during exercise and recovery using an impedance cardiography device (PhysioFlow^®^, Enduro model, Manatec, France) as previously published \[[@pone.0183791.ref019], [@pone.0183791.ref020], [@pone.0183791.ref023]\]. This noninvasive technique was previously found to be valid, accurate, and reproducible at rest and during exercise in healthy subjects and CHD patients \[[@pone.0183791.ref024]--[@pone.0183791.ref029]\]. Data were averaged every 15 consecutive heartbeats for cardiac index (CI: in l/min^/^m^2^, stroke volume index (SVi: in ml/m^2^), heart rate (in beats/min), end-diastolic and end-systolic volume index (EDVi and ESVi: in ml/m^2^), left cardiac work index (LCWi: in kg.m/m^2^), left ventricular ejection fraction (in %) and systemic vascular resistance index (SVRi: in dynes/s/cm^5^/m^2^).

Statistical analysis {#sec009}
--------------------

Results are presented as mean ± standard deviation except where otherwise indicated. Statistical analysis was performed using Statview software 5.0 and SAS version 9.4 (SAS, Cary, USA). Normal Gaussian distribution of the data was verified by the Shapiro--Wilk test. A one-way ANOVA (groups) was used to compare cardiopulmonary, hemodynamic and cognitive function variables. A two-way ANOVA (groups x time) was performed to compare brain NIRS parameters data during exercise and recovery between healthy controls and CHD patients. A Bonferroni post-hoc test was used to localize differences. Statistical significance was set at P\<0.05 level for all analysis. Relationships between $\overset{˙}{V}\text{O}_{2}$ peak, CI max, NIRS variables and cognitive function items were performed using a Pearson coefficient of correlation (R) and statistical significance was corrected according to the number of correlations and set at P\<0.005. Composite scores were calculated form the neuropsychological battery that assessed four cognitive domains: memory, speed of processing, executive functioning and verbal memory. All cognitive scores were first transformed in standardized z-scores and then averaged to provide a composite score for each domain. The composite z score were calculated as follow: 1) working memory = (forward + backward z scores)/2, 2) Speed of processing = (DSST+Trail A+Stroop 1+Stroop 2 z scores)/4, 3) Executive functioning = (Trail B+Stroop 3+Stroop 4 z scores)/3, 4) Verbal memory = (Immediate recall + delayed recall + Recognition + A1-15 z scores)/4. We sought to identify predictors of each of these four composite z score. Univariate analysis using Spearman correlation coefficient (to account for light deviation from normal distribution) was first performed to highlight potential predictors. All variables that showed a p≤0.05 in the univariate analysis were included in a stepwise linear regression analysis to identify independent predictors of each composite z score. Despite the light deviation from normal distribution for some predictors, the analysis of the residuals for each model shows that all underlying assumptions of linear regression were respected without the need to use data transformation. For a multiple linear regression model on predicting cognitive function which already includes 5 covariates with a squared multiple correlation R^2^ of 0.50, a sample size of 80 will have 80% power to detect at alpha = 0.05 an increase in R^2^ of 0.046 due to including the factor of interest (ex: ΔO~2~Hb). The number of covariates (ex: from 1 to 15) has only a very small effect on the results.

Results {#sec010}
=======

Clinical characteristics {#sec011}
------------------------

Baseline characteristics of all three groups are outlined in [Table 1](#pone.0183791.t001){ref-type="table"}. The prevalence of traditional risk factors was significantly higher in patients with CHD relative to age-matched controls, both of these groups being significantly older than young healthy controls (See the Results section on Clinical characteristics of the [S1 File](#pone.0183791.s001){ref-type="supplementary-material"} for details).

10.1371/journal.pone.0183791.t001

###### Clinical characteristics in young, old healthy controls and CHD patients.

![](pone.0183791.t001){#pone.0183791.t001g}

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                        Young healthy controls\                                                                                                                                               Old healthy controls\                                                                 Patients with CHD\
                                                        (*n* = 22)                                                                                                                                                            (*n* = 20)                                                                            (*n* = 25)
  ----------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------- --------------------
  Age (years)                                           33 ± 11 [^a^](#t001fn005){ref-type="table-fn"}^,^[^b^](#t001fn006){ref-type="table-fn"} [^§^](#t001fn010){ref-type="table-fn"}                                        67 ± 6                                                                                70 ± 8

  Height (cm)                                           173 ± 6                                                                                                                                                               170 ± 8                                                                               170 ± 8

  Female sex                                            7 (31%)                                                                                                                                                               4 (20%)                                                                               2 (8%)

  Smoking                                               0 (0%)                                                                                                                                                                0 (0%)                                                                                0 (0%)

  Hypertension [^1^](#t001fn001){ref-type="table-fn"}   0 (0%)                                                                                                                                                                0 (0%)                                                                                15 (60%)

  Diabetes [^2^](#t001fn002){ref-type="table-fn"}       0 (0%)                                                                                                                                                                0 (0%)                                                                                7 (28%)

  History of dyslipidemia                               0 (0%)                                                                                                                                                                2 (10%)                                                                               20 (80%)

  Obesity [^3^](#t001fn003){ref-type="table-fn"}        0 (0%)                                                                                                                                                                0 (0%)                                                                                11 (44%)

  Prior MI                                              0 (0%)                                                                                                                                                                0 (0%)                                                                                10 (40%)

  Prior PCI                                             0 (0%)                                                                                                                                                                0 (0%)                                                                                9 (36%)

  Prior CABG                                            0 (0%)                                                                                                                                                                0 (0%)                                                                                8 (32%)

  **Medication**                                                                                                                                                                                                                                                                                                    

  Beta--blockers                                        0 (0%)                                                                                                                                                                0 (0%)                                                                                14 (58%)

  ACE inhibitors                                        0 (0%)                                                                                                                                                                0 (0%)                                                                                8 (32%)

  Antiplatelet agents                                   0 (0%)                                                                                                                                                                0 (0%)                                                                                24 (96%)

  Angiotensin receptor blockers                         0 (0%)                                                                                                                                                                0 (0%)                                                                                6 (24%)

  Statin                                                0 (0%)                                                                                                                                                                1 (5%)                                                                                23 (92%)

  Calcium channel blockers                              0 (0%)                                                                                                                                                                1 (5%)                                                                                9 (36%)

  Nitrates                                              0 (0%)                                                                                                                                                                0 (0%)                                                                                3 (12%)

  Hypoglycemic agents                                   0 (0%)                                                                                                                                                                0 (0%)                                                                                3 (12%)

  **Body composition**                                                                                                                                                                                                                                                                                              

  Body mass (kg)                                        69 ± 8 [^b^](#t001fn006){ref-type="table-fn"}[\*](#t001fn008){ref-type="table-fn"}                                                                                    70 ± 8 [^c^](#t001fn007){ref-type="table-fn"}[\*](#t001fn008){ref-type="table-fn"}    77 ± 11

  BMI (kg/m^2^)                                         23 ± 2 [^b^](#t001fn006){ref-type="table-fn"}[^§^](#t001fn010){ref-type="table-fn"}                                                                                   24 ± 1 [^c^](#t001fn007){ref-type="table-fn"}[^†^](#t001fn009){ref-type="table-fn"}   26 ± 2

  Waist circumference (cm)                              83 ± 7 [^b^](#t001fn006){ref-type="table-fn"}[^§^](#t001fn010){ref-type="table-fn"}                                                                                   89 ± 7 [^c^](#t001fn007){ref-type="table-fn"}[^†^](#t001fn009){ref-type="table-fn"}   97 ± 9

  Lean body mass (kg)                                   57 ± 8                                                                                                                                                                55 ± 9                                                                                57 ± 8

  FM percentage (%)                                     18 ± 7 [^a^](#t001fn005){ref-type="table-fn"}[\*](#t001fn008){ref-type="table-fn"}^,^ [^b^](#t001fn006){ref-type="table-fn"}[^§^](#t001fn010){ref-type="table-fn"}    22 ± 4 [^c^](#t001fn007){ref-type="table-fn"}[\*](#t001fn008){ref-type="table-fn"}    26 ± 5

  Trunk FM percentage (%)                               16 ± 7 [^a^](#t001fn005){ref-type="table-fn"}[^†^](#t001fn009){ref-type="table-fn"}^,^ [^b^](#t001fn006){ref-type="table-fn"}[^§^](#t001fn010){ref-type="table-fn"}   22 ± 4 [^c^](#t001fn007){ref-type="table-fn"}[^§^](#t001fn010){ref-type="table-fn"}   28 ± 5
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^1^ Rest SBP ≥ 130 mmHg;

^2^ glucose ≥ 7 mmol/l;

^3^ BMI \> 30 kg/m^2^

Group effect:

^a^ = young vs. older,

^b^ = young vs. CHD patients,

^c^ = older vs. CHD patients,

\* = P\<0.05,

^†^ = P\<0.01,

^§^ = P\<0.0001.

ACE, angiotensin--converting enzyme; CABG, coronary artery bypass grafting surgery; CHD, coronary heart disease; MI, myocardial infarction; PCI, percutaneous coronary intervention. BMI: body mass index, FM: fat mass, SBP: systolic blood pressure, DBP: diastolic blood pressure.

Cognitive function parameters {#sec012}
-----------------------------

[Table 2](#pone.0183791.t002){ref-type="table"} describes cognitive function parameters in all three groups. Briefly, except for GDS which was similar between groups, young healthy control subjects scored significantly higher on all tasks followed by age-matched controls then CHD patients. (See the Results section on Cognitive function parameters of the [S1 File](#pone.0183791.s001){ref-type="supplementary-material"} for details).

10.1371/journal.pone.0183791.t002

###### Cognitive function parameters in young, old healthy controls and CHD patients.

![](pone.0183791.t002){#pone.0183791.t002g}

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                   Young healthy controls\                                                                                                                                                     Old healthy controls\                                                                        Patients with CHD\   ANOVA\
                                                   (*n* = 22)                                                                                                                                                                  (*n* = 20)                                                                                   (*n* = 25)           P value
  ------------------------------------------------ --------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------- -------------------- ----------
  **Education (years)**                            17 ± 1 [^a^](#t002fn002){ref-type="table-fn"}[\*](#t002fn005){ref-type="table-fn"}^,^[^b^](#t002fn003){ref-type="table-fn"}[\*](#t002fn005){ref-type="table-fn"}            14 ± 3                                                                                       15 ± 3               0.0277

  **Mental disease / depression symptomatology**                                                                                                                                                                                                                                                                                                 

  GDS (/30)                                        1.7 ± 1.3                                                                                                                                                                   1.8 ± 1.9                                                                                    3.1 ± 3.2            0.2072

  MMSE (/30)                                       29.2 ± 0.8 [^b^](#t002fn003){ref-type="table-fn"}[^†^](#t002fn006){ref-type="table-fn"}                                                                                     28.7 ± 1.1                                                                                   28.1 ± 1.1           0.0107

  **Short term and working memory**                                                                                                                                                                                                                                                                                                              

  Forward Span                                     11.9 ± 1.7 [^a^](#t002fn002){ref-type="table-fn"}[^‡^](#t002fn007){ref-type="table-fn"}^,^[^b^](#t002fn003){ref-type="table-fn"}[^§^](#t002fn008){ref-type="table-fn"}      9.9 ± 1.3 [^c^](#t002fn004){ref-type="table-fn"}[^†^](#t002fn006){ref-type="table-fn"}       8.3 ± 1.7            \<0.0001

  Backward Span                                    8.6 ± 2.7 [^b^](#t002fn003){ref-type="table-fn"}[^§^](#t002fn008){ref-type="table-fn"}                                                                                      7.4 ± 2.0 [^c^](#t002fn004){ref-type="table-fn"}[^†^](#t002fn006){ref-type="table-fn"}       5.7 ± 1.6            \<0.0001

  **Perceptual abilities and processing speed**                                                                                                                                                                                                                                                                                                  

  DSST                                             88.7 ± 12.0 [^a^](#t002fn002){ref-type="table-fn"}[^§^](#t002fn008){ref-type="table-fn"}^,^[^b^](#t002fn003){ref-type="table-fn"}[^§^](#t002fn008){ref-type="table-fn"}     65.8 ± 13.2 [^c^](#t002fn004){ref-type="table-fn"}[^†^](#t002fn006){ref-type="table-fn"}     55.1 ± 13.8          \<0.0001

  Trail A (s)                                      23.35 ± 7.99 [^a^](#t002fn002){ref-type="table-fn"}[^§^](#t002fn008){ref-type="table-fn"}^,^[^b^](#t002fn003){ref-type="table-fn"}[^§^](#t002fn008){ref-type="table-fn"}    40.80 ± 10.93                                                                                43.93 ± 12.65        \<0.0001

  Stroop 1(s)                                      24.05 ± 3.90 [^a^](#t002fn002){ref-type="table-fn"}[^†^](#t002fn006){ref-type="table-fn"}^,^[^b^](#t002fn003){ref-type="table-fn"}[^§^](#t002fn008){ref-type="table-fn"}    31.60 ± 7.82                                                                                 32.82 ± 7.28         0.0003

  Stroop 2 (s)                                     17.81 ± 2.29 [^a^](#t002fn002){ref-type="table-fn"}[^†^](#t002fn006){ref-type="table-fn"}^,^[^b^](#t002fn003){ref-type="table-fn"}[^†^](#t002fn006){ref-type="table-fn"}    23.74 ± 8.82                                                                                 22.31 ± 3.29         0.0043

  **Cognitive inhibition and flexibility**                                                                                                                                                                                                                                                                                                       

  Trail B (s)                                      48.99 ± 13.99 [^a^](#t002fn002){ref-type="table-fn"}[^†^](#t002fn006){ref-type="table-fn"}^,^[^b^](#t002fn003){ref-type="table-fn"}[^§^](#t002fn008){ref-type="table-fn"}   77.62 ± 20.32 [^c^](#t002fn004){ref-type="table-fn"}[^†^](#t002fn006){ref-type="table-fn"}   112.24 ± 47.26       \<0.0001

  Stroop 3 (s)                                     38.66 ± 11.41 [^a^](#t002fn002){ref-type="table-fn"}[^‡^](#t002fn007){ref-type="table-fn"}^,^[^b^](#t002fn003){ref-type="table-fn"}[^§^](#t002fn008){ref-type="table-fn"}   55.38 ± 12.79 [^c^](#t002fn004){ref-type="table-fn"}[^†^](#t002fn006){ref-type="table-fn"}   67.34 ± 14.01        \<0.0001

  Stroop 4 (s)                                     44.84 ± 5.11 [^a^](#t002fn002){ref-type="table-fn"}[\*](#t002fn005){ref-type="table-fn"}^,^[^b^](#t002fn003){ref-type="table-fn"}[^§^](#t002fn008){ref-type="table-fn"}     62.07 ± 22.22 [^c^](#t002fn004){ref-type="table-fn"}[^†^](#t002fn006){ref-type="table-fn"}   78.78 ± 23.56        \<0.0001

  **Long term verbal memory**                                                                                                                                                                                                                                                                                                                    

  Immediate Recall                                 12.9 ± 1.7 [^a^](#t002fn002){ref-type="table-fn"}[^†^](#t002fn006){ref-type="table-fn"}^,^[^b^](#t002fn003){ref-type="table-fn"}[^§^](#t002fn008){ref-type="table-fn"}      10.4 ± 2.4 [^c^](#t002fn004){ref-type="table-fn"}[^†^](#t002fn006){ref-type="table-fn"}      7.9 ± 3.4            \<0.0001

  Delayed Recall                                   13.2 ± 1.5 [^a^](#t002fn002){ref-type="table-fn"}[^†^](#t002fn006){ref-type="table-fn"}^,^[^b^](#t002fn003){ref-type="table-fn"}[^§^](#t002fn008){ref-type="table-fn"}      9.8 ± 2.5 [^c^](#t002fn004){ref-type="table-fn"}[^†^](#t002fn006){ref-type="table-fn"}       7.3 ± 3.8            \<0.0001

  Recognition                                      14.7 ± 0.5 [^a^](#t002fn002){ref-type="table-fn"}[^†^](#t002fn006){ref-type="table-fn"}^,^[^b^](#t002fn003){ref-type="table-fn"}[^‡^](#t002fn007){ref-type="table-fn"}      13.2 ± 1.5                                                                                   12.8 ± 2.0           0.0008

  A1-15                                            60.3 ± 6.6 [^a^](#t002fn002){ref-type="table-fn"}[^‡^](#t002fn007){ref-type="table-fn"}^,^[^b^](#t002fn003){ref-type="table-fn"}[^§^](#t002fn008){ref-type="table-fn"}      48.7 ± 9.8 [^c^](#t002fn004){ref-type="table-fn"}[^†^](#t002fn006){ref-type="table-fn"}      39.6 ± 11.3          \<0.0001
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

GDS: Geriatric Depression Scale, MMSE: Mini-Mental State Examination, DSST: Digit Symbol Substitution Test. Group effect:

^a^ = young vs. older,

^b^ = young vs. CHD patients,

^c^ = older vs. CHD patients,

\* = P\<0.05,

^†^ = P\<0.01,

^‡^ = P\<0.001,

^§^ = P\<0.0001.

Cardiopulmonary exercise and hemodynamic parameters {#sec013}
---------------------------------------------------

[Table 3](#pone.0183791.t003){ref-type="table"} describes cardiopulmonary exercise and hemodynamic parameters in all three groups. Both $\overset{˙}{V}\text{O}_{2}$ peak and cardiac index were significantly higher among young healthy subjects followed by age-matched control and CHD patients. Importantly, $\overset{˙}{V}\text{O}_{2}$ peak was between 110 and 140% higher relative to age-predicted values depending upon the group, indicating a physically fit sample (all groups). (See the Results section on Cardiopulmonary exercise and hemodynamic parameters of the [S1 File](#pone.0183791.s001){ref-type="supplementary-material"} for details).

10.1371/journal.pone.0183791.t003

###### Cardiopulmonary exercise testing data in young, old healthy controls and CHD patients.

![](pone.0183791.t003){#pone.0183791.t003g}

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Cardiopulmonary and hemodynamic variables                Young healthy controls\                                                                                                                                                    Old healthy controls\                                                                     Patients with CHD\   ANOVA\
                                                           (*n* = 22)                                                                                                                                                                 (*n* = 20)                                                                                (*n* = 25)           P value
  -------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------- -------------------- ----------
  **Rest**                                                                                                                                                                                                                                                                                                                                           

  Resting heart rate (bpm)                                 61 ± 11                                                                                                                                                                    65 ± 8                                                                                    70 ± 14              0.0536

  Resting CI (l/min/m^2^)                                  3.10 ± 0.52                                                                                                                                                                2.72 ± 0.43                                                                               2.77 ± 0.63          0.0778

  LVEF (%)                                                 61 ± 7 [^b^](#t003fn003){ref-type="table-fn"}[^†^](#t003fn006){ref-type="table-fn"}                                                                                        55 ± 7                                                                                    53 ± 7               0.0071

  Rest SBP (mmHg)                                          116 ± 8 [^b^](#t003fn003){ref-type="table-fn"}[\*](#t003fn005){ref-type="table-fn"}                                                                                        119 ± 14 [^c^](#t003fn004){ref-type="table-fn"}[^†^](#t003fn006){ref-type="table-fn"}     127 ± 16             0.0155

  Rest DBP (mmHg)                                          70 ± 6                                                                                                                                                                     72 ± 10                                                                                   73 ± 8               0.6404

  **At peak**                                                                                                                                                                                                                                                                                                                                        

  $\overset{˙}{V}\text{O}_{2}$ peak (ml/min/LBM)           59 ± 8 [^a^](#t003fn002){ref-type="table-fn"}[^§^](#t003fn008){ref-type="table-fn"}^,^ [^b^](#t003fn003){ref-type="table-fn"}[^§^](#t003fn008){ref-type="table-fn"}        42 ± 6 [^c^](#t003fn004){ref-type="table-fn"}[\*](#t003fn005){ref-type="table-fn"}        36 ± 8               \<0.0001

  \% of $\overset{˙}{V}\text{O}_{2}$ peak predicted (%)    139 ± 20 [^b^](#t003fn003){ref-type="table-fn"}[^§^](#t003fn008){ref-type="table-fn"}                                                                                      138 ± 17 [^c^](#t003fn004){ref-type="table-fn"}[^§^](#t003fn008){ref-type="table-fn"}     110 ± 22             \<0.0001

  $\overset{˙}{V}\text{CO}_{2}$ (ml/min)                   4017 ± 961 [^a^](#t003fn002){ref-type="table-fn"}[^§^](#t003fn008){ref-type="table-fn"}^,^[^b^](#t003fn003){ref-type="table-fn"}[^§^](#t003fn008){ref-type="table-fn"}     2703 ± 813                                                                                2385 ± 837           \<0.0001

  R.E.R                                                    1.20 ± 0.05                                                                                                                                                                1.15 ± 0.06                                                                               1.16 ± 0.09          0.1012

  Peak power (Watts)                                       273 ± 59 [^a^](#t003fn002){ref-type="table-fn"}[^§^](#t003fn008){ref-type="table-fn"}^,^[^b^](#t003fn003){ref-type="table-fn"}[^§^](#t003fn008){ref-type="table-fn"}       189 ± 55 [^c^](#t003fn004){ref-type="table-fn"}[^†^](#t003fn006){ref-type="table-fn"}     138 ± 51             \<0.0001

  $\overset{˙}{V}\text{Epeak}$ (l/min)                     122 ± 29 [^a^](#t003fn002){ref-type="table-fn"}[^‡^](#t003fn007){ref-type="table-fn"}^,^[^b^](#t003fn003){ref-type="table-fn"}[^§^](#t003fn008){ref-type="table-fn"}       88 ± 31                                                                                   80 ± 24              \<0.0001

  \% of $\overset{˙}{V}\text{Epeak}$ predicted (%)         154 ± 26 [^b^](#t003fn003){ref-type="table-fn"}[^‡^](#t003fn007){ref-type="table-fn"}                                                                                      139 ± 32 [^c^](#t003fn004){ref-type="table-fn"}[\*](#t003fn005){ref-type="table-fn"}      119 ± 30             0.0007

  $\overset{˙}{V}\text{E}$/$\overset{˙}{V}\text{CO}_{2}$   34 ± 5                                                                                                                                                                     32 ± 5                                                                                    35 ± 5               0.0759

  VT (liters)                                              2.69 ± 0.54 [^b^](#t003fn003){ref-type="table-fn"}[^‡^](#t003fn007){ref-type="table-fn"}                                                                                   2.42 ± 0.56                                                                               2.13 ± 0.41          0.0017

  CI max (l/min/m^2^)                                      10.43 ± 1.90 [^a^](#t003fn002){ref-type="table-fn"}[^‡^](#t003fn007){ref-type="table-fn"}^,^[^b^](#t003fn003){ref-type="table-fn"}[^§^](#t003fn008){ref-type="table-fn"}   8.71 ± 1.82 [^c^](#t003fn004){ref-type="table-fn"}[\*](#t003fn005){ref-type="table-fn"}   7.44 ± 1.37          \<0.0001

  Δ CI max (l/min/m^2^)                                    7.33 ± 1.77 [^a^](#t003fn002){ref-type="table-fn"}[\*](#t003fn005){ref-type="table-fn"}^,^[^b^](#t003fn003){ref-type="table-fn"}[^§^](#t003fn008){ref-type="table-fn"}     6.01 ± 1.99 [^c^](#t003fn004){ref-type="table-fn"}[\*](#t003fn005){ref-type="table-fn"}   4.66 ± 1.23          \<0.0001

  Peak HR (puls/min)                                       184 ± 11 [^a^](#t003fn002){ref-type="table-fn"}[^§^](#t003fn008){ref-type="table-fn"}^,^[^b^](#t003fn003){ref-type="table-fn"}[^§^](#t003fn008){ref-type="table-fn"}       155 ± 10 [^c^](#t003fn004){ref-type="table-fn"}[^§^](#t003fn008){ref-type="table-fn"}     132 ± 21             \<0.0001

  Heart rate reserve (%)                                   97 ± 7 [^a^](#t003fn002){ref-type="table-fn"}[\*](#t003fn005){ref-type="table-fn"}^,^[^b^](#t003fn003){ref-type="table-fn"}[^§^](#t003fn008){ref-type="table-fn"}          87 ± 11 [^c^](#t003fn004){ref-type="table-fn"}[^§^](#t003fn008){ref-type="table-fn"}      69 ± 18              \<0.0001

  HRR at 1 min (puls)                                      \- 23 ± 8                                                                                                                                                                  -20 ± 6                                                                                   \- 18 ± 7            0.0903

  Max SBP (mmHg)                                           184 ± 18                                                                                                                                                                   185 ± 26                                                                                  177 ± 24             0.4335

  Max DBP (mmHg)                                           74 ± 8                                                                                                                                                                     80 ± 11                                                                                   78 ± 9               0.0903
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

LVEF: left ventricular ejection fraction, SBP: systolic blood pressure, DBP: diastolic blood pressure, LBM: lean body mass, R.E.R: respiratory exchange ratio, VT: volume tidal, Bf: breathing frequency, CI: cardiac index, ΔCI max = CI max- Resting CI, C(a-v)O~2~: arterio venous difference, SVi: stroke volume index, LCWi: left cardiac work index, SVRi: systemic vascular resistance index, HR: heart rate, HRR: heart rate recovery, Group effect:

^a^ = young vs. older,

^b^ = young vs. CHD patients,

^c^ = older vs. CHD patients,

\* = P\<0.05,

^†^ = P\<0.01,

^‡^ = P\<0.001,

^§^ = P\<0.0001.

Left prefrontal NIRS parameters during exercise and recovery {#sec014}
------------------------------------------------------------

Figs [2a, 2b, 2c, 2d](#pone.0183791.g002){ref-type="fig"}, [3a, 3b, 3c and 3d](#pone.0183791.g003){ref-type="fig"} describes left prefrontal NIRS parameters during exercise and recovery in all three groups. All parameters were similar at baseline and increased progressively until peak exercise. However, ΔO~2~ Hb and ΔtHb were significantly higher at peak exercise in young healthy controls relative to CHD patients and age-matched healthy controls (P\<0.01). (See the Results section on Left prefrontal NIRS parameters during exercise and recovery of the [S1 File](#pone.0183791.s001){ref-type="supplementary-material"} for details).

![(a-d): Brain NIRS parameters during exercise in young (YC), old healthy controls (OC) and CHD patients (CHD).\
Post hoc for group effect = a: young vs. old, b = young vs. CHD, \* = P\<0.05, † = P\<0.01, ‡ = P\<0.001, § = P\<0.0001.](pone.0183791.g002){#pone.0183791.g002}

![(a-d): Brain NIRS parameters during recovery in young (YC), old healthy controls (OC) and CHD patients (CHD).\
Post hoc for group effect = a: young vs. old, b = young vs. CHD, c = old vs. CHD, \* = P\<0.05, † = P\<0.01, ‡ = P\<0.001, § = P\<0.0001.](pone.0183791.g003){#pone.0183791.g003}

Relationships between $\overset{˙}{V}\text{O}_{2}$ peak, maximal cardiac index, left prefrontal NIRS and cognitive function parameters {#sec015}
--------------------------------------------------------------------------------------------------------------------------------------

The relationships between $\overset{˙}{V}\text{O}_{2}$ peak, CI max, left prefrontal NIRS parameters (ΔO~2~ Hb, ΔHHb, ΔtHb, ΔHb diff.) and selected cognitive tasks are described in the Table A and B in [S2 File](#pone.0183791.s002){ref-type="supplementary-material"} (see the Results section of the [S1 File](#pone.0183791.s001){ref-type="supplementary-material"}). In summary, statistically significant univariate relationships were observed between all cognitive tasks and both $\overset{˙}{V}\text{O}_{2}$ peak and CI max, while most cognitive tasks were significantly associated with NIRS parameters.

Stepwise multiple regression analysis {#sec016}
-------------------------------------

[Table 4(A)--4(D)](#pone.0183791.t004){ref-type="table"} describes univariate and multivariate analyses used to identify independent predictors of each cognitive composite z score. The relationship between composite z scores representing four cognitive domains (memory, speed of processing, executive functions and verbal memory) and CV risk factors, body composition, exercise and NIRS parameters are presented in [Table 4](#pone.0183791.t004){ref-type="table"}. Briefly, trunk fat mass, education and diabetes were independent predictors of composite working memory score, while maximal total hemoglobin (ΔtHbmax) was the only independent predictor of the speed of processing score. Age and LDL-cholesterol were independent predictors for executive functioning score, whereas $\overset{˙}{V}\text{O}_{2}$ peak /LBM and gender were independent predictors of the verbal memory score.

10.1371/journal.pone.0183791.t004

###### (A-D): Univariate and multivariate analyses used to identify predictors of each cognitive composite z score.

![](pone.0183791.t004){#pone.0183791.t004g}

  ------------------------------------------------------------ --------------------- ----------------------- --------- ----------
  **A: Predictors of working memory composite score**                                                                  
  Variables                                                    Univariate analysis   Multivariate analysis             
  R                                                            P value               Beta                    P value   
  Age                                                          -0.682                \<0.0001                          
  Education                                                    0.435                 0.0006                  0.066     0.0314
  Height                                                       0.277                 0.0321                            
  Gender                                                       0.145                 0.2671                            
  Obesity                                                      -0.363                0.0044                            
  Type 2 diabetes                                              -0.326                0.0108                  -0.644    0.0103
  Hypertension                                                 -0.419                0.0009                            
  Dyslipidemias                                                -0.460                0.0002                            
  Body mass                                                    -0.164                0.2102                            
  BMI                                                          -0.413                0.0010                            
  WC                                                           -0.347                0.0108                            
  Fat mass                                                     -0.374                0.0045                            
  Trunk fat mass                                               -0.491                0.0001                  -0.049    0.0014
  Fasting glucose                                              -0.374                0.0067                            
  Tot chol                                                     0.358                 0.0099                            
  HDL                                                          0.314                 0.0245                            
  LDL                                                          0.279                 0.0474                            
  TG                                                           -0.189                0.1832                            
  TG/HDL                                                       -0.310                0.0263                            
  $\overset{˙}{V}\text{O}_{2}$ peak /LBM                       0.587                 \<0.0001                          
  $\overset{˙}{V}\text{O}_{2}$ peak in % of predicted value    0.2167                0.1053                            
  CImax                                                        0.474                 0.0001                            
  O~2~Hbmax                                                    0.457                 0.0003                            
  O~2~HB recovery                                              0.345                 0.0073                            
  HHbmax                                                       0.264                 0.0429                            
  HHb recovery                                                 0.164                 0.2119                            
  tHb max                                                      0.528                 \<0.0001                          
  tHb recovery                                                 0.451                 0.0003                            
  Hb Diff max                                                  0.404                 0.0015                            
  Hb Diff recovery                                             0.320                 0.0134                            
  SBP rest                                                     -0.258                0.0484                            
  DBP rest                                                     -0.059                0.6551                            
  **B: Predictors of speed of processing composite score**                                                             
  Variables                                                    Univariate analysis   Multivariate analysis             
  R                                                            P value               Beta                    P value   
  Age                                                          0.482                 0.0001                            
  Education                                                    -0.325                0.0143                            
  Height                                                       -0.222                0.0967                            
  Gender                                                       -0.012                0.9284                            
  Obesity                                                      0.109                 0.4193                            
  Type 2 diabetes                                              0.100                 0.4558                            
  Hypertension                                                 0.086                 0.5247                            
  Dyslipidemias                                                0.292                 0.0270                            
  Body mass                                                    0.093                 0.4893                            
  BMI                                                          0.251                 0.0596                            
  WC                                                           0.171                 0.2281                            
  Fat mass                                                     0.330                 0.0156                            
  Trunk fat mass                                               0.331                 0.0153                            
  Fasting glucose                                              0.093                 0.5245                            
  Tot chol                                                     -0.108                0.4566                            
  HDL                                                          -0.035                0.8082                            
  LDL                                                          -0.086                0.5545                            
  TG                                                           -0.012                0.9338                            
  TG/HDL                                                       0.052                 0.7212                            
  $\overset{˙}{V}\text{O}_{2}$ peak /LBM                       -0.306                0.0204                            
  $\overset{˙}{V}\text{O}_{2}$ peak in % of predicted value    0.040                 0.7699                            
  CImax                                                        -0.434                0.0007                            
  O~2~Hbmax                                                    -0.392                0.0028                            
  O~2~HB recovery                                              -0.191                0.1579                            
  HHbmax                                                       -0.126                0.3529                            
  HHb recovery                                                 -0.149                0.2720                            
  tHb max                                                      -0.461                0.0003                  -0.038    0.0047
  tHb recovery                                                 -0.329                0.0130                            
  Hb Diff max                                                  -0.354                0.0074                            
  Hb Diff recovery                                             -0.065                0.6332                            
  SBP rest                                                     0.069                 0.6128                            
  DBP rest                                                     0185                  0.1703                            
  **C: Predictors of executive functioning composite score**                                                           
  Variables                                                    Univariate analysis   Multivariate analysis             
  R                                                            P value               Beta                    P value   
  Age                                                          0.848                 \<0.0001                0.035     \<0.0001
  Education                                                    -0.356                0.0070                            
  Height                                                       -0.343                0.0088                            
  Gender                                                       -0.243                0.0683                            
  Obesity                                                      0.386                 0.0030                            
  Type 2 diabetes                                              0.172                 0.2002                            
  Hypertension                                                 0.409                 0.0016                            
  Dyslipidemias                                                0.525                 \<0.0001                          
  Body mass                                                    0.052                 0.6995                            
  BMI                                                          0.312                 0.0180                            
  WC                                                           0.305                 0.0292                            
  Fat mass                                                     0.435                 0.0011                            
  Trunk fat mass                                               0.574                 \<0.0001                          
  Fasting glucose                                              0.309                 0.0304                            
  Tot chol                                                     -0.307                0.0089                            
  HDL                                                          -0.221                0.1257                            
  LDL                                                          -0.323                0.0235                  -0.284    0.0103
  TG                                                           0.274                 0.0561                            
  TG/HDL                                                       0.346                 0.0146                            
  $\overset{˙}{V}\text{O}_{2}$ peak /LBM                       -0.768                \<0.0001                          
  $\overset{˙}{V}\text{O}_{2}$ peak in % of predicted value    -0.385                0.0033                            
  CImax                                                        -0.575                \<0.0001                          
  O~2~Hbmax                                                    -0.651                \<0.0001                          
  O~2~HB recovery                                              -0.268                0.0458                            
  HHbmax                                                       -0.252                0.0607                            
  HHb recovery                                                 -0.219                0.1041                            
  tHb max                                                      -0.707                \<0.0001                          
  tHb recovery                                                 -0.584                \<0.0001                          
  Hb Diff max                                                  -0.570                \<0.0001                          
  Hb Diff recovery                                             -0.357                0.0069                            
  SBP rest                                                     0.249                 0.0641                            
  DBP rest                                                     0.119                 0.3822                            
  **D: Predictors of verbal memory composite score**                                                                   
  Variables                                                    Univariate analysis   Multivariate analysis             
  R                                                            P value               Beta                    P value   
  Age                                                          -0.700                \<0.0001                          
  Education                                                    0.431                 0.0006                            
  Height                                                       0.258                 0.0460                            
  Gender                                                       0.338                 0.0082                  0.678     0.0419
  Obesity                                                      -0.325                0.0112                            
  Type 2 diabetes                                              -0.115                0.3798                            
  Hypertension                                                 -0.238                0.0660                            
  Dyslipidemias                                                -0.305                0.0177                            
  Body mass                                                    -0.378                0.0029                            
  BMI                                                          -0.346                0.0110                            
  WC                                                           -0.346                0.0110                            
  Fat mass                                                     -0.254                0.0581                            
  Trunk fat mass                                               -0.400                0.0022                            
  Fasting glucose                                              -0.115                0.4203                            
  Tot chol                                                     0.241                 0.0883                            
  HDL                                                          0.282                 0.0447                            
  LDL                                                          0.134                 0.3470                            
  TG                                                           -0.180                0.2038                            
  TG/HDL                                                       -0.280                0.0426                            
  $\overset{˙}{V}\text{O}_{2}$ peak /LBM                       0.656                 \<0.0001                0.044     0.0002
  $\overset{˙}{V}\text{O}_{2}$ peak in % of predicted value    0.368                 0.0047                            
  CImax                                                        0.337                 0.0084                            
  O~2~Hbmax                                                    0.483                 0.0001                            
  O~2~HB recovery                                              0.266                 0.0413                            
  HHbmax                                                       0.443                 0.0004                            
  HHb recovery                                                 0.368                 0.0041                            
  tHb max                                                      0.582                 \<0.0001                          
  tHb recovery                                                 0.480                 0.0001                            
  Hb Diff max                                                  0.397                 0.0018                            
  Hb Diff recovery                                             0.335                 0.0093                            
  SBP rest                                                     -0.281                0.0307                            
  DBP rest                                                     0.024                 0.8558                            
  ------------------------------------------------------------ --------------------- ----------------------- --------- ----------

Discussion {#sec017}
==========

Major findings {#sec018}
--------------

The main findings of this study are that: 1) CHD patients despite being fit, scored significantly worse on cognitive tests relating to short-term and working memory, processing speed, inhibition and flexibility and long-term verbal memory compared to fit age-matched and young healthy controls, 2) cerebral oxygenation/perfusion during exercise was significantly lower among CHD patients and age-matched controls relative to young controls and 3) executive and memory cognitive functions correlated with $\overset{˙}{V}\text{O}_{2}$ peak, maximal cardiac index and cerebral oxygenation/perfusion (ΔO~2~ ΔHHb, ΔtHb) during exercise among the entire cohort. To the best of our knowledge, this study is the first to relate executive cognitive functions with simultaneous measures of cardiopulmonary and cardiac function, and cerebral hemodynamics. Our data further support the hypothesis that cardiac function plays a role in the normal decline in cognitive function with aging, and that high fitness alone as a consequence of regular exercise training is insufficient to prevent this decline although it may be slowed.

Cognitive function in fit cohorts {#sec019}
---------------------------------

A large and growing body of evidence highlights the positive relationship that exists between cardiorespiratory fitness and cognitive function in both middle-aged \[[@pone.0183791.ref030]\] and older healthy adults \[[@pone.0183791.ref031], [@pone.0183791.ref032]\]. Furthermore, higher fitness at a younger age is predictive of better cognitive function later on in life \[[@pone.0183791.ref033], [@pone.0183791.ref034]\]. These data are also consistent with others showing the benefits of exercise training on cognitive function in otherwise healthy individuals \[[@pone.0183791.ref011]\]. Correlates of this association include structural differences (greater white matter, cerebral blood flow etc.). Few data, however, exist regarding cognitive function in highly fit individuals, and particularly in those with chronic disease. A recent study in elderly marathon runners (mean age 66 years, functional capacity 140% of predicted) demonstrated better cognitive function in one executive function domain (non-verbal fluency assessed via Five Point Test) relative to age-matched controls, while all other executive functions were similar between groups. In a small study in Masters Athletes (n = 12, mean age 72 years), letter and category fluency were significantly better relative to both sedentary elderly and young controls, while other cognitive domains were similar between all three groups \[[@pone.0183791.ref035]\]. Despite the fact that the prevalence of cognitive decline is higher among patients with CHD or vascular risk factors \[[@pone.0183791.ref036]--[@pone.0183791.ref042]\], no studies however have evaluated whether fitness level influences cognitive function among such subjects with CHD. Our data would indicate that regular physical activity and high fitness level are insufficient to prevent the "step-down" in cognitive function that occurs from healthy age-matched controls to older patients with CHD. One explanation for this persistence difference could include irreversible vascular changes whereby exercise is no longer able to exert its beneficial effects on the cerebral vasculature. Other potential explanations include a higher prevalence of irreversible brain lesions in patients with CHD such as white matter lesions, brain infarcts and brain atrophy, which also would not be expected to respond to exercise training. Furthermore, CHD patients were already receiving optimal pharmacologic therapy for vascular disease including 92% on statins and 96% on antiplatelet agents and vascular function may have already been at the maximal achievable level.

Cerebral oxygenation during exercise and recovery {#sec020}
-------------------------------------------------

We observed higher cerebral oxygenation (ΔO~2~ Hb) and perfusion (ΔtHb) among healthy subjects during exercise (from 50 to 100% of $\overset{˙}{V}\text{O}_{2}$ peak) and recovery (0 to 5 min) relative to the two older groups (CHD and age-matched controls). Furthermore, patients with CHD showed evidence of reduced cerebral oxygenation (ΔO~2~ Hb) and perfusion (ΔtHb) during recovery only compared to healthy age-matched controls. Two previous studies demonstrated that aging is associated with a reduction in cerebral perfusion \[[@pone.0183791.ref012], [@pone.0183791.ref043]\] during exercise. The first study (using simultaneous arterial and jugular venous blood gases) showed a similar cerebral oxygen extraction in young and old healthy subjects \[[@pone.0183791.ref043]\], whereas a second one demonstrated lower right prefrontal cerebral oxygenation and perfusion (ΔO~2~ Hb, ΔtHb) using NIRS in older subjects \[[@pone.0183791.ref012]\] consistent with our results. The age-related differences in cerebral oxygenation and perfusion we observed could potentially be explained by cerebral vascular aging. This phenomenon includes stiffening of the carotid arteries thereby increasing blood pulsatility in the brain microcirculation, reduced cerebral vascular conductance, brain endothelial dysfunction and reduced brain capillary density \[[@pone.0183791.ref043], [@pone.0183791.ref044]\]. The impact of CVD on cerebral oxygenation and perfusion would appear to depend upon the severity of cardiac dysfunction. For example, one study observed no difference in cerebral exercise oxygenation (ΔO~2~ Hb) or perfusion (ΔtHb) among patients with New York Heart Association (NYHA) class II heart failure and healthy controls, whereas a reduced cerebral oxygenation/perfusion was demonstrated in patients with NYHA class III heart failure vs. the same healthy control group \[[@pone.0183791.ref010]\]. As well, two other studies demonstrated reduced cerebral oxygenation (ΔO~2~ Hb) and perfusion (ΔtHb) using NIRS during exercise and recovery in patients with valvular heart disease or idiopathic dilated cardiomyopathy with reduced left ventricular ejection fraction (\<40%) as compared to older aged-matched healthy controls \[[@pone.0183791.ref008], [@pone.0183791.ref009]\]. Similarly to our results, no differences in cerebral exercise oxygenation (ΔO~2~ Hb) and perfusion (ΔtHb) were observed in heart failure patients (NHYA class II) and healthy controls \[[@pone.0183791.ref010]\]. We believe that the etiology of heart disease (stable CHD vs. valvular and heart failure), our preserved patient's aerobic capacity and left ventricular ejection fraction (data not shown) may explain the lack of difference during exercise. In agreement with a previous study in heart failure patients \[[@pone.0183791.ref009]\], post-exercise cerebral oxygenation (ΔO~2~ Hb) and perfusion (ΔtHb) were reduced in patients with CHD. These results could be attributed to a lower overshoot of cardiac output during recovery in CHD patients vs. older healthy controls \[[@pone.0183791.ref009], [@pone.0183791.ref010]\].

Cognitive function parameters and their relationships with $\overset{˙}{V}\text{O}_{2}$ peak, cardiac and cerebral hemodynamics {#sec021}
-------------------------------------------------------------------------------------------------------------------------------

We found that $\overset{˙}{V}\text{O}_{2}$ peak, maximal cardiac output (CI max) and cerebral oxygenation and perfusion (ΔO~2~ Hb, ΔtHb) during exercise and, to a lesser degree during recovery, were related to resting cognitive function (short term and working memory, psychomotor speed, cognitive inhibition and flexibility and long term verbal memory) in agreement with previous studies in healthy subjects, heart failure and transplanted patients \[[@pone.0183791.ref010], [@pone.0183791.ref011], [@pone.0183791.ref045]\]. The results are also in accordance with the cerebrovascular reserve hypothesis that highlight that better cognitive function relates to better cerebrovascular responses \[[@pone.0183791.ref013]\]. Moreover, independent predictors for cognitive function (composite score) were also identified. They included education, diabetes, and trunk adiposity for working memory and gender and aerobic fitness for verbal memory. In two studies in obese subjects and heart failure patients, obesity, gender and education were also predictors of memory \[[@pone.0183791.ref046], [@pone.0183791.ref047]\]. In contrast, in a previous work in CHD patients, aerobic fitness ($\overset{˙}{V}\text{O}_{2}$ peak) was not an independent predictor of memory function \[[@pone.0183791.ref048]\]. Cerebral perfusion during exercise (tHbmax) independently predicted speed of processing in our study. Previously, resting cerebral perfusion (MRI) was shown not to be related to trail making A (a component of speed of processing score) in multiple linear regression models in older adults with CV disease \[[@pone.0183791.ref014]\], Finally, we found that age and LDL-cholesterol were independent predictors of executive functioning. Age is a known predictor of executive function in healthy subjects and cardiac patients \[[@pone.0183791.ref011], [@pone.0183791.ref046]\], however we have no clear explanation why LDL-cholesterol remained in the models except as a possible marker of cerebral atherosclerosis. In addition, we are surprised that ($\overset{˙}{V}\text{O}_{2}$ peak) was not independently related to executive function as shown in other previous studies in healthy subjects and CHD patients \[[@pone.0183791.ref048], [@pone.0183791.ref049]\].

Limitations {#sec022}
-----------

Our study has limitations, including the enrolment of healthy subjects and stable selected CHD patients (mostly men) recruited in a single centre, hence inducing a potential recruitment bias. Patients with CHD were also receiving optimal or near-optimal medical therapy and following a preventive cardiology program. Results may differ in women and in other CHD patients (ex: following acute coronary syndromes) in the real-world setting. As well, cerebral oxygenation and perfusion were assessed non-invasively using NIRS at the left prefrontal area level implicating a very limited spatial resolution and a relatively superficial brain tissue measurement (light penetration ≈ 2.25 cm). Therefore, our results may differ from other more invasive and global measurement of brain oxygenation and perfusion (ex: catheters) or from other brain regions. Another limitation is that cognitive function was only assessed at rest and not during exercise (e.g: Stroop task) in our subjects sample.

Conclusions {#sec023}
-----------

In this study, we demonstrate that fit CHD patients show evidence of significantly reduced resting cognitive functions, particularly with respect to the executive and memory domains, relative to age-matched healthy controls and younger controls. These data indicate that fitness alone does not or cannot prevent the clear step-down in cognitive functions that occur in patients with CHD relative to age-matched healthy controls. Furthermore, while the aging process itself is associated with reduced cognitive function, based upon our results, it is unclear what role reduced cerebral oxygenation/perfusion and cardiopulmonary and hemodynamic responses play in explaining the impairments in cognitive function we observed in our fit CHD cohort. Larger studies using several imaging modalities for evaluating cerebral blood flow and oxygenation/perfusion are required to better understand the potential role of cerebrovascular and neurovascular function in explaining the cognitive impairments we observed in our two aged cohorts. Finally, studies of pharmacological and non-pharmacological treatments known to improve vascular function should be conducted in order to evaluate their potential impact on cognitive functions and assess potential mechanisms. For example, high-intensity interval training was recently shown to have superior effects on $\overset{˙}{V}\text{O}_{2}$ peak, cardiac output, and cerebral perfusion in patients with chronic heart failure \[[@pone.0183791.ref050]\] and could be a promising approach to enhance cognitive functions in subjects with CVD.
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